[在帕金森病中保持姿势稳定和行走]
D V Pokhabov1,2, M E Tunik1, D D Pokhabov1,2
1Federal Clinical Scientifical Center of the Federal Medical Biological Agency, Krasnoyarsk, Russia.
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
|November 23, 2023
概括
本综述涵盖了帕金森病的运动障碍,重点是治疗姿势不稳定. 皮里贝迪尔 (Piribedil) 是一种多巴胺激动剂,主要用于纠正这些衰弱症状.
科学领域:
- 神经学 神经学
- 运动障碍 运动障碍
背景情况:
- 帕金森病 (PD) 是一种进展性神经退行性疾病,其特点是运动症状,包括运动障碍.
- 姿势不稳定是帕金森病的一个重要且经常导致残疾的症状,影响患者的流动性和生活质量.
研究的目的:
- 提供当前对帕金森病运动障碍的挑战和治疗策略的概述.
- 对PD患者体位不稳定性治疗和康复的最新文献进行审查.
- 专门研究多巴胺受体激动剂 (如皮里贝迪尔) 在控制这些症状中的作用.
主要方法:
- 关于帕金森病,运动障碍和姿势不稳定的最近研究的文献综述.
- 对姿势不稳定的治疗和康复方法的分析.
- 专注于药理干预措施,特别是多巴胺受体激动剂.
主要成果:
- 目前的文献强调了管理帕金森病运动障碍的重大挑战.
- 对姿势不稳定的有效治疗和康复策略对于改善患者的治疗结果至关重要.
- 多巴胺受体激动剂,以皮里贝迪尔为例,在纠正与PD相关的特定运动障碍方面表现有前途.
结论:
- 帕金森病的综合管理需要解决各种运动障碍.
- 针对姿势不稳定的向治疗对于提高PD患者的功能独立性至关重要.
- 皮里贝迪尔代表了一种有价值的治疗选择,用于纠正帕金森病中的运动障碍.
相关概念视频
01:15Parkinson's Disease: Overview
560
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
560
01:24Parkinson's Disease: Treatment
278
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
278